PATIENT-DERIVED XENOGRAFTS OF MATCHED PRIMARY-RECURRENT PEDIATRIC BRAIN TUMORS AS A RESOURCE FOR IDENTIFYING THERAPY RESISTANCE PROFILESNEURO-ONCOLOGYIF13.42023-06-120OAAI
Derivation and validation of risk prediction for posttraumatic stress symptoms following trauma exposurePSYCHOLOGICAL MEDICINEIF5.52022-07-015PRE
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82021-02-0714PREAI
Novel Wide-Band Dielectric Imaging System and Occlusion Tool to Guide Cryoballoon-Based Pulmonary Vein Isolation Feasibility and First InsightsCIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGYIF9.82020-12-0113OA
First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-DefibrillatorJACC-CLINICAL ELECTROPHYSIOLOGYIF7.72020-11-0133OAAI
Performance of a convolutional neural network derived from an ECG database in recognizing myocardial infarctionSCIENTIFIC REPORTSIF3.92020-05-2160OAAI
Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives心房颤动的导管消融: 最新技术和未来展望CARDIOLOGY AND THERAPYIF2.72020-01-0262OAAI
Predictors of Manuscript Rejection sYndrome (MiSeRY): a cohort studyMEDICAL JOURNAL OF AUSTRALIAIF8.52019-12-088OAAI
Velocity characteristics of atrial fibrillation sources determined by electrographic flow mapping before and after catheter ablationINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22019-07-0116PREAI
Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82019-01-0121OAAI
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trialsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82018-08-0149OAAI
Identification of active atrial fibrillation sources and their discrimination from passive rotors using electrographical flow mappingCLINICAL RESEARCH IN CARDIOLOGYIF3.72018-05-0931PREAI
Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation RegistryJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32018-03-2029OAAI
Bronchial Injury After Atrial Fibrillation Ablation Using the Second-Generation CryoballoonCIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGYIF9.82018-03-014OAAI
Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closureHEART RHYTHMIF5.72018-01-0126OAAI
Pulmonary vein stenosis or occlusion after catheter ablation of atrial fibrillation: long-term comparison of drug-eluting versus large bare metal stentsEUROPACEIF7.42017-10-2427OAAI
Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillationINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22017-09-0115PREAI
Cryoballoon ablation in the elderly: one year outcome and safety of the second-generation 28mm cryoballoon in patients over 75 years oldEUROPACEIF7.42017-06-2727OAAI